Chihiro Yabe
Corporate Officer/Principal at Kyoto Prefectural University of Medicine
Profile
Chihiro Yabe is the founder of Calliditas Therapeutics Suisse SA, which was founded in 2006.
Currently, Dr. Yabe holds the position of Professor at Kyoto Prefectural University of Medicine.
Chihiro Yabe active positions
| Companies | Position | Start |
|---|---|---|
| Kyoto Prefectural University of Medicine | Corporate Officer/Principal | - |
Former positions of Chihiro Yabe
| Companies | Position | End |
|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Chihiro Yabe
